共 50 条
- [1] A randomized, double-blind, phase III study of pembrolizumab plus chemotherapy as first-line therapy in patients with HER2-negative, advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: KEYNOTE-859ANNALS OF ONCOLOGY, 2020, 31 : S1316 - S1317Qin, S.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R China Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R ChinaTabernero, J.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R Chinavan Cutsem, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Digest Oncol, Campus Gasthuisberg, Leuven, Belgium Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R ChinaFuchs, C. S.论文数: 0 引用数: 0 h-index: 0机构: Yale Canc Ctr, Med Oncol, New Haven, CT USA Smilow Canc Hosp, New Haven, CT USA Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R ChinaJanjigian, Y. Y.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R ChinaBhagia, P.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R ChinaLi, K.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R ChinaAdelberg, D.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Med Oncol, Kenilworth, NJ USA Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R ChinaBang, Y-J.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Coll, Internal Med Med Oncol, Seoul, South Korea Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R China
- [2] KEYNOTE-859: A randomized, double-blind, placebo-controlled phase 3 trial of first-line pembrolizumab plus chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinomaANNALS OF ONCOLOGY, 2020, 31 : S101 - S102Tabernero, J.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Barcelona, Spain Vall dHebron Inst Oncol, Barcelona, Spain Vall dHebron Univ Hosp, Barcelona, SpainBang, Y.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ Hosp, Coll Med, Seoul, South Korea Vall dHebron Univ Hosp, Barcelona, SpainVan Cutsem, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg Leuven & KU Leuven, Leuven, Belgium Vall dHebron Univ Hosp, Barcelona, SpainFuchs, C.论文数: 0 引用数: 0 h-index: 0机构: Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA Vall dHebron Univ Hosp, Barcelona, SpainJanjigian, Y.论文数: 0 引用数: 0 h-index: 0机构: MSKCC, New York, NY USA Vall dHebron Univ Hosp, Barcelona, SpainBhagia, P.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Vall dHebron Univ Hosp, Barcelona, SpainLi, K.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Vall dHebron Univ Hosp, Barcelona, SpainAdelberg, D.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Vall dHebron Univ Hosp, Barcelona, SpainQin, S.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Jinling Hosp, PLA Canc Ctr, Nanjing, Peoples R China Vall dHebron Univ Hosp, Barcelona, Spain
- [3] Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trialNATURE MEDICINE, 2024, 30 (07) : 1943 - 1951Gao, Xiangyu论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaJi, Ke论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Gastrointestinal Canc Ctr, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaJia, Yongning论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaShan, Fei论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaChen, Ye论文数: 0 引用数: 0 h-index: 0机构: Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaXu, Nong论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaJia, Ziyu论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Gastrointestinal Canc Ctr, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaLiu, Tianshu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hosp, Shanghai, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaYang, Nong论文数: 0 引用数: 0 h-index: 0机构: Hunan Canc Hosp, Changsha, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaZhong, Haijun论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Canc Hosp, Hangzhou, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaLi, Changzheng论文数: 0 引用数: 0 h-index: 0机构: Shandong Canc Hosp, Jinan, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaGuo, Zengqing论文数: 0 引用数: 0 h-index: 0机构: Fujian Canc Hosp, Fuzhou, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaFan, Qingxia论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaLin, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaZhang, Yan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Gastrointestinal Canc Ctr, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaRen, Hui论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Gastrointestinal Canc Ctr, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaYang, Hongxia论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Gastrointestinal Canc Ctr, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaYao, Zhifang论文数: 0 引用数: 0 h-index: 0机构: Akeso Biopharm Inc, Zhongshan, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaLiu, Wei论文数: 0 引用数: 0 h-index: 0机构: Akeso Biopharm Inc, Zhongshan, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaWang, Zhongmin Maxwell论文数: 0 引用数: 0 h-index: 0机构: Akeso Biopharm Inc, Zhongshan, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaLi, Baiyong论文数: 0 引用数: 0 h-index: 0机构: Akeso Biopharm Inc, Zhongshan, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaXia, Michelle论文数: 0 引用数: 0 h-index: 0机构: Akeso Biopharm Inc, Zhongshan, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaShen, Lin论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaLi, Ziyu论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Gastrointestinal Canc Ctr, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R ChinaJi, Jiafu论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, State Key Lab Holist Integrat Management Gastroint, Beijing Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
- [4] Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trialMEDICAL ONCOLOGY, 2015, 32 (10)Ochenduszko, Sebastian论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, Poland Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, PolandPuskulluoglu, Miroslawa论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, Poland Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, PolandKonopka, Kamil论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Krakow, Dept Clin Oncol, Krakow, Poland Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, Poland论文数: 引用数: h-index:机构:Urbanczyk, Katarzyna论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian Univ, Coll Med, Dept Pathol, PL-31531 Krakow, Poland Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, PolandBudzynski, Andrzej论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian Univ, Coll Med, Dept Gen Surg 2, PL-31531 Krakow, Poland Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, Poland论文数: 引用数: h-index:机构:Lazar, Agata论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian Univ, Coll Med, Dept Pathol, PL-31531 Krakow, Poland Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, PolandSinczak-Kuta, Anna论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian Univ, Coll Med, Dept Pathol, PL-31531 Krakow, Poland Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, PolandPedziwiatr, Michal论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian Univ, Coll Med, Dept Gen Surg 2, PL-31531 Krakow, Poland Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, PolandKrzemieniecki, Krzysztof论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, Poland Jagiellonian Univ, Coll Med, Dept Oncol, PL-31531 Krakow, Poland
- [5] Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trialMedical Oncology, 2015, 32Sebastian Ochenduszko论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyMiroslawa Puskulluoglu论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyKamil Konopka论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyKamil Fijorek论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyKatarzyna Urbanczyk论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyAndrzej Budzynski论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyMaciej Matlok论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyAgata Lazar论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyAnna Sinczak-Kuta论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyMichal Pedziwiatr论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of OncologyKrzysztof Krzemieniecki论文数: 0 引用数: 0 h-index: 0机构: Jagiellonian University Medical College,Department of Oncology
- [6] Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialLANCET ONCOLOGY, 2023, 24 (11): : 1181 - 1195Rha, Sun Young论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaOh, Do-Youn论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaYanez, Patricio论文数: 0 引用数: 0 h-index: 0机构: Univ La Frontera, James Lind Canc Res Ctr, Dept Internal Med, Temuco, Chile Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaBai, Yuxian论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ, Canc Hosp, Dept Gastrointestinal Oncol, Harbin, Peoples R China Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea论文数: 引用数: h-index:机构:Lee, Jeeyun论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol, Seoul, South Korea Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaRivera, Fernando论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Marques de Valdecilla, Dept Med Oncol, IDIVAL, Santander, Spain Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaAlves, Gustavo Vasconcelos论文数: 0 引用数: 0 h-index: 0机构: Hosp Nossa Senhora Conceicao, Ctr Integrado Pesquisa Oncol, Porto Alegre, Brazil Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaGarrido, Marcelo论文数: 0 引用数: 0 h-index: 0机构: Pontificia Univ Catolica Chile, Dept Hematooncol, Santiago, Chile Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaShiu, Kai-Keen论文数: 0 引用数: 0 h-index: 0机构: NHS Fdn Trust, Univ Coll London Hosp, Univ Coll London Canc Inst, Gastrointestinal Oncol Serv, London, England Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaFernandez, Manuel Gonzalez论文数: 0 引用数: 0 h-index: 0机构: IMAT Oncomed, Hemato Oncol, Monteria, Colombia Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaLi, Jin论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Shanghai East Hosp, Dept Med Oncol, Sch Med, Shanghai, Peoples R China Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaLowery, Maeve A.论文数: 0 引用数: 0 h-index: 0机构: Trinity St James Canc Inst, Dept Med Oncol, Dublin, Ireland Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaCil, Timucin论文数: 0 引用数: 0 h-index: 0机构: Hlth & Sci Univ, Dept Med Oncol, Adana City Hosp, Adana, Turkiye Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaCruz, Felipe Melo论文数: 0 引用数: 0 h-index: 0机构: Inst Brasileiro Controle Canc, Dept Med Oncol, Sao Paulo, Brazil Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaQin, Shukui论文数: 0 引用数: 0 h-index: 0机构: Canc Ctr Peoples Liberat Army, Dept Med Oncol, Nanjing, Peoples R China Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaLuo, Suxia论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Dept Med Oncol, Zhengzhou, Peoples R China Henan Canc Hosp, Zhengzhou, Peoples R China Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaPan, Hongming论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Med Oncol, Hangzhou, Peoples R China Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaWainberg, Zev A.论文数: 0 引用数: 0 h-index: 0机构: UCLA, David Geffen Sch Med, Los Angeles, CA USA Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaYin, Lina论文数: 0 引用数: 0 h-index: 0机构: Merck, Biostat & Res Decis Sci, Rahway, NJ USA Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaBordia, Sonal论文数: 0 引用数: 0 h-index: 0机构: Merck, Global Clin Dev, Rahway, NJ USA Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaBhagia, Pooja论文数: 0 引用数: 0 h-index: 0机构: Merck, Global Clin Dev, Rahway, NJ USA Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South KoreaWyrwicz, Lucjan S.论文数: 0 引用数: 0 h-index: 0机构: Maria Sklodowska Curie Natl Res Inst Oncol, Dept Oncol & Radiotherapy, Warsaw, Poland Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea
- [7] Sintilimab plus chemotherapy (chemo) versus chemo as first-line treatment for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (ORIENT-16): First results of a randomized, double-blind, phase III studyANNALS OF ONCOLOGY, 2021, 32 : S1331 - S1331Xu, J.论文数: 0 引用数: 0 h-index: 0机构: Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaJiang, H.论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Hangzhou, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaPan, Y.论文数: 0 引用数: 0 h-index: 0机构: Anhui Prov Hosp, Dept Oncol Chemotherapy, Hefei, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaGu, K.论文数: 0 引用数: 0 h-index: 0机构: Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaCang, S.论文数: 0 引用数: 0 h-index: 0机构: Henan Prov Peoples Hosp, Dept Oncol, Zhengzhou, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaHan, L.论文数: 0 引用数: 0 h-index: 0机构: Jining Med Univ, Affiliated Hosp, Dept Oncol, Jining, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaShu, Y.论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Canc Ctr, Nanjing, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaLi, J.论文数: 0 引用数: 0 h-index: 0机构: Xiamen Univ, Affiliated Hosp 1, Dept Oncol, Xiamen, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaZhao, J.论文数: 0 引用数: 0 h-index: 0机构: Qinghai Univ, Affiliated Hosp, Dept Oncol, Xining, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaPan, H.论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Sir Run Run Shaw Hosp, Med Sch, Dept Oncol, Hangzhou, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaLuo, S.论文数: 0 引用数: 0 h-index: 0机构: Henan Canc Hosp, Dept Gastroenterol, Zhengzhou, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaQin, Y.论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaGuo, Q.论文数: 0 引用数: 0 h-index: 0机构: Taizhou Hosp Zhejiang Prov, Dept Hematol, Taizhou, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaBai, Y.论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ, Affiliated Tumor Hosp, Dept Gastroenterol, Harbin, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaLing, Y.论文数: 0 引用数: 0 h-index: 0机构: Changzhou Tumor Hosp, Dept Oncol, Changzhou, Jiangsu, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaGuo, Y.论文数: 0 引用数: 0 h-index: 0机构: Innovent Biol Suzhou Co Ltd, Dept Biostat, Beijing, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaLi, Z.论文数: 0 引用数: 0 h-index: 0机构: Innovent Biol Suzhou Co Ltd, Dept Med Sci & Strategy Oncol, Shanghai, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaLiu, Y.论文数: 0 引用数: 0 h-index: 0机构: Innovent Biol Suzhou Co Ltd, Dept Med Sci & Strategy Oncol, Shanghai, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaWang, Y.论文数: 0 引用数: 0 h-index: 0机构: Innovent Biol Suzhou Co Ltd, Dept Med Sci & Strategy Oncol, Beijing, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R ChinaZhou, H.论文数: 0 引用数: 0 h-index: 0机构: Innovent Biol Suzhou Co Ltd, Dept Med Sci & Strategy Oncol, Shanghai, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Oncol, Beijing, Peoples R China
- [8] Assessment of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients (pts) with advanced HER2-negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Morano, Federica论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyNiger, Monica论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyCorallo, Salvatore论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyLonardi, Sara论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyTamberi, Stefano论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyDi Donato, Samantha论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyGiommoni, Elisa论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyGiuliani, Francesco论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyFrassineti, Giovanni Luca论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyTomasello, Gianluca论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyDe Vita, Ferdinando论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyCardellino, Giovanni Gerardo论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyPinotti, Graziella论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyBrizzi, Maria Pia论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyRimassa, Lorenza论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyScartozzi, Mario论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyBerardi, Rossana论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyDe Braud, Filippo G.论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyPietrantonio, Filippo论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, ItalyDi Bartolomeo, Maria论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy
- [9] First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 StudyADVANCES IN THERAPY, 2025, : 1892 - 1906Qin, Shukui论文数: 0 引用数: 0 h-index: 0机构: China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R China Canc Ctr Peoples Liberat Army, Nanjing, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaBai, Yuxian论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ, Canc Hosp, Harbin, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaLi, Jin论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Shanghai East Hosp, Sch Med, Shanghai, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaPan, Hongming论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Sir Run Shaw Hosp, Sch Med, Hangzhou, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaLuo, Suxia论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China Henan Canc Hosp, Zhengzhou, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaQu, Yanli论文数: 0 引用数: 0 h-index: 0机构: Xinjiang Med Univ, Canc Hosp, Xinjiang, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaYe, Feng论文数: 0 引用数: 0 h-index: 0机构: Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaYang, Lin论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc, Beijing, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaLiu, Tianshu论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp Affiliated, Shanghai, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaLi, Wei论文数: 0 引用数: 0 h-index: 0机构: China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaChen, Xi论文数: 0 引用数: 0 h-index: 0机构: 900th Hosp Joint Logist Support Force Chinese Peop, Fuzhou, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaYang, Jianwei论文数: 0 引用数: 0 h-index: 0机构: Fujian Prov Canc Hosp, Fuzhou, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaYing, Jieer论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Canc Hosp, Hangzhou, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaLin, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaZhao, Lin论文数: 0 引用数: 0 h-index: 0机构: Peking Union Med Coll Hosp, Beijing, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaLiang, Xinjun论文数: 0 引用数: 0 h-index: 0机构: Hubei Canc Hosp, Wuhan, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaMao, Yixiang论文数: 0 引用数: 0 h-index: 0机构: Msd China, Shanghai, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaGuo, Run论文数: 0 引用数: 0 h-index: 0机构: Msd China, Beijing, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaZuo, Yi论文数: 0 引用数: 0 h-index: 0机构: Msd China, Beijing, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaBordia, Sonal论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Rahway, NJ USA China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R ChinaLi, Shouguo论文数: 0 引用数: 0 h-index: 0机构: Xiamen Univ, Zhongshan Hosp, Xiamen, Peoples R China China Pharmaceut Univ, Nanjing Tianyinshan Hosp, GI Canc Ctr, 3789 Jieyin Rd, Nanjing 210000, Jiangsu, Peoples R China
- [10] Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 studyANNALS OF ONCOLOGY, 2023, 34 (03) : 319 - 320Rha, S. Y.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South Korea Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaWyrwicz, L. S.论文数: 0 引用数: 0 h-index: 0机构: Mar Sklodowska Curie Natl Res Inst Oncol, Oncol & Radiotherapy, Warsaw, Poland Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaWeber, P. E. Y.论文数: 0 引用数: 0 h-index: 0机构: Univ La Frontera, James Lind Canc Res Ctr, Internal Med, Temuco, Chile Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaBai, Y.论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ, Canc Hosp, Gastrointestinal Oncol, Harbin, Peoples R China Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaRyu, M. H.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Oncol, Coll Med, Seoul, South Korea Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaLee, J.论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr SMC, Hematol & Oncol, Sch Med, Seoul, South Korea Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaRivera, F.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Marques de Valdecilla, Med Oncol, Santander, Spain Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaAlves, G. V.论文数: 0 引用数: 0 h-index: 0机构: Hosp Nossa Senhora Conceicao, Med Oncol, Porto Alegre, Brazil Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaGarrido, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Mayor, Oncol, Santiago, Chile Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaShiu, K. -k.论文数: 0 引用数: 0 h-index: 0机构: Univ Coll Hosp NHS Fdn Trust, Oncol, London, England Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaFernandez, M. Gonzalez论文数: 0 引用数: 0 h-index: 0机构: IMAT Oncomed, Monteria, Colombia Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaLi, J.论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Shanghai East Hosp, Med Oncol, Sch Med, Shanghai, Peoples R China Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaLowery, M.论文数: 0 引用数: 0 h-index: 0机构: Trinity St James Canc Inst, Med Oncol, Dublin, Ireland Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaCil, T.论文数: 0 引用数: 0 h-index: 0机构: Hlth & Sci Univ, Adana City Hosp, Med Oncol, Adana, Turkiye Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaCruz, F. J. S. M.论文数: 0 引用数: 0 h-index: 0机构: Nucleo Pesquisa & Ensino Rede Sao Camilo, Med Oncol, Sao Paulo, Brazil Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaQin, S.论文数: 0 引用数: 0 h-index: 0机构: Canc Ctr Peoples Liberat Army, Med Oncol, Nanjing, Peoples R China Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaYin, L.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Biostat & Res Decis Sci, Rahway, NJ USA Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaBordia, S.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Global Clin Dev, Rahway, NJ USA Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaBhagia, P.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Global Clin Dev, Rahway, NJ USA Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South KoreaOh, D-y.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Internal Med, Coll Med, Seoul, South Korea Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Internal Med, Seoul, South Korea